Compound class:
Synthetic organic
Comment: Compound 27 is a lead ERK1/2 inhibitor that was identified using biophysical fragment screening and structure-based optimization [1]. It was found to be potent, selective and orally bioavailable. Compound 27 inhibits both the catalytic kinase (phosphorylating) activity of ERK1/2, and the phosphorylation of ERK1/2. It is an alternative chemotype to SCH772984, but it retains the dual activity profile that was originally identified in SCH772984. Compound 27 has improved in vivo exposure compared to SCH772984.
(Note: ERK1= MAPK3, ERK2= MAPK1). ![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
Compound 27 reduced both pRSK (a downstream phosphorylation target of ERK, the IC50 for this effect is 3.5 nM) and pERK1/2 levels (IC50 2.3 nM) in mutant BRAF cells in vitro and in vivo [1], the latter action indicating potential utility in tumours with acquired resistance to current BRAF inhibitors. It also suppressed pERK and pRSK levels in human colon carcinoma (Colo205) xenograft models and xenograft regression was observed after 15 days of treatment. Off-targets (kinases inhibited by >50% at 100 nM): protein kinases D1 and D2 (PRKD1, PRKD2), and mitogen-activated protein kinase 15 (MAPK15/ERK7). Further off-targets that are inhibited by >50% at 1 μM compound 27 are listed in Supplementary Table 1 [1]. |
Selectivity at enzymes | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|